Table 3.

Risk for drug resistance among different clinic settings

Type of healthcare setting	Unadjusted risk for drug resistance			Adjusted risk adjusted for marital status, barriers of adherence, time on ART a
	OR	95% CI	p-value	OR	95% CI	p-value
Private	2.66	1.24-5.73	0.012	2.53	1.13-5.66	0.02
Public-private	0.91	0.44-1.90	0.809	1.17	0.51-2.69	0.72
Public	1 (reference category)			1 (reference category)

^a Factors that were not significantly associated were gender, residence, education, income, disclosure status, side effects, and regimen switch.